Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
about
Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidenceOspemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data.Pharmacological management of osteogenesis.Ospemifene use in postmenopausal women.Incorporation of raloxifene-impregnated allograft around orthopedic titanium implants impairs early fixation but improves new bone formation.Effects of CreERT2, 4-OH Tamoxifen, and Gender on CFU-F AssaysIn Vivo Study on the Pharmacological Interactions between a Chinese Herbal Formula ELP and Antiresorptive Drugs to Counteract OsteoporosisPotential of selective estrogen receptor modulators as treatments and preventives of breast cancer.Measuring selective estrogen receptor modulator (SERM)-membrane interactions with second harmonic generationPharmacologic evaluation of ospemifene.Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapy.Ospemifene: first global approval.Selective estrogen receptor modulators in clinical practice: a safety overview.Pharmacokinetics, pharmacodynamics and clinical efficacy of ospemifene for the treatment of dyspareunia and genitourinary syndrome of menopause.Reciprocal osteoblastic and osteoclastic modulation in co-cultured MG63 osteosarcoma cells and human osteoclast precursors.Paracrine-mediated osteoclastogenesis by the osteosarcoma MG63 cell line: is RANKL/RANK signalling really important?Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients.Tamoxifen stimulates calcitonin-producing thyroid C-cells and prevents trabecular bone loss in a rat model of androgen deficiency.Responses of urinary N-telopeptide and renal calcium handling to PTH infusion after treatment with estrogen, raloxifene, and tamoxifen.
P2860
Q30380010-0EAED69A-C9C0-437F-A1F5-E08AB9973BA9Q30491704-D44608B1-5303-4126-AE65-62860032DA71Q33729548-F25DE82A-9FF4-4930-BC6A-E168C09B3294Q34982860-722DE738-F192-4104-BE2D-DA8D92C1FB37Q35197585-6AC84125-AE2A-48DB-BF73-B8BFE49C3D8CQ35909527-6C2A4E03-CB32-4EA0-941E-17F4E876481DQ36369348-00042339-2E2A-4C3C-8C0E-D75F95FF8C09Q37156496-772E3BB2-902F-4C0D-BC99-D955EB9AC0D7Q37731586-0FAE4C14-3625-4F66-A9DF-B5DB9FF6E581Q37739433-AEE93716-BECB-43C9-B528-B08027CE1942Q38016531-452C2E13-4757-42D3-90A2-7810F55C429BQ38100714-F8C9E053-E1E9-40BE-AE52-979DDD839E25Q38455538-852BB4BE-DA7B-488F-BEA2-D65BB97D74A7Q38836000-0C7378BD-5661-4E86-BDE4-08816E8242F3Q39495372-F6A4177E-33F5-4456-AE63-BFC51799F546Q39561248-52962F64-1A6A-4CC4-8F8A-47ABEE4B47C1Q48119309-31052871-94D7-4DE5-8BE8-469C5EB008D1Q52953036-7FEC3B88-43D6-42BD-90A3-6C570349F6DBQ53669167-3CBF175F-C3D6-4653-AC38-5B3A780CC649
P2860
Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Differential effects of select ...... on human osteoclasts in vitro.
@ast
Differential effects of select ...... on human osteoclasts in vitro.
@en
type
label
Differential effects of select ...... on human osteoclasts in vitro.
@ast
Differential effects of select ...... on human osteoclasts in vitro.
@en
prefLabel
Differential effects of select ...... on human osteoclasts in vitro.
@ast
Differential effects of select ...... on human osteoclasts in vitro.
@en
P2093
P2860
P356
P1476
Differential effects of select ...... on human osteoclasts in vitro.
@en
P2093
H K Väänänen
P L Härkönen
T A Hentunen
P2860
P304
P356
10.1038/SJ.BJP.0707232
P407
P577
2007-04-10T00:00:00Z